Work

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial

Year: 2015

Type: article

Study design: Clinical Trial

Source: Stroke

DOI: 10.1161/strokeaha.115.010260

Authors: Opeolu Adeoye, Heidi Sucharew, Jane Khoury, Achala Vagal, Pamela A. Schmit, Irene Ewing, Steven R. Levine, Stacie Demel, Bryan Eckerle, Brian Katz, Dawn Kleindorfer, Brian Stettler, Daniel Woo, Pooja Khatri, Joseph P. Broderick, Arthur M. Pancioli

Institutions: Cincinnati Children's Hospital Medical Center, State University of New York, SUNY Downstate Health Sciences University, Kings County Hospital Center, University of Cincinnati

Language: English

Topic: Acute Ischemic Stroke Management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences

Awards: Cerebrovascular Fellowship Training Program, G2388603646, Recanalization Therapies and Markers of Stroke Outcome

OpenAlex ID: W2563068144

FWCI: 4.359

Cites: 19

Cited by: 73

Related to: 10